We are live on ! Find out more
JP Morgan Chase

JP Morgan Chase Portfolio holdings

AUM $1.81T
1-Year Est. Return 41.13%
 

JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.

This Fund
S&P 500
This Quarter Est. Return
-13.28%
1 Year Est. Return
+41.13%
3 Year Est. Return
+122.17%
5 Year Est. Return
+152.24%
10 Year Est. Return
+601.59%
AUM
$718B
AUM Growth
-$112B
Cap. Flow
+$11.7B
Cap. Flow %
1.63%
Top 10 Hldgs %
17.54%
Holding
7,270
New
568
Increased
2,561
Reduced
2,729
Closed
610

Sector Composition

Rank Sector Weight
1 Technology 15.03%
2 Healthcare 12.52%
3 Financials 10.5%
4 Consumer Discretionary 7.88%
5 Industrials 7.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADRT.WS
6001
DELISTED
Ault Disruptive Technologies Corporation Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50
ADRT.WS
0
MF
6002
DELISTED
Missfresh Limited American Depositary Shares
MF
$3K ﹤0.01%
376
+21
+6% +$329
CEMI
6003
DELISTED
Chembio diagnostics, Inc.
CEMI
$3K ﹤0.01%
3,894
-599
-13% -$398
AFRM icon
6004
PUT
Affirm
AFRM
$24.6B
$2K ﹤0.01%
+100
New +$2.72K
ALGS icon
6005
Aligos Therapeutics
ALGS
$43.7M
$2K ﹤0.01%
63
-524
-89% -$17.8K
ANIX icon
6006
Anixa Biosciences
ANIX
$110M
$2K ﹤0.01%
650
BETZ icon
6007
Roundhill Sports Betting & iGaming ETF
BETZ
$49.7M
$2K ﹤0.01%
145
CABA icon
6008
Cabaletta Bio
CABA
$465M
$2K ﹤0.01%
1,598
-2,110
-57% -$2.98K
CHY
6009
Calamos Convertible and High Income Fund
CHY
$1.09B
$2K ﹤0.01%
+162
New +$2.01K
CRVS icon
6010
Corvus Pharmaceuticals
CRVS
$1.27B
$2K ﹤0.01%
1,968
-3,531
-64% -$4.33K
CUT icon
6011
Invesco MSCI Global Timber ETF
CUT
$33.4M
$2K ﹤0.01%
55
DFNL icon
6012
Davis Select Financial ETF
DFNL
$493M
$2K ﹤0.01%
+87
New +$2.46K
EOS
6013
Eaton Vance Enhance Equity Income Fund II
EOS
$1.18B
$2K ﹤0.01%
+120
New +$2.17K
ETY icon
6014
Eaton Vance Tax-Managed Diversified Equity Income Fund
ETY
$2.35B
$2K ﹤0.01%
+146
New +$1.81K
FCEL icon
6015
CALL
FuelCell Energy
FCEL
$1.73B
$2K ﹤0.01%
+13
New +$1.64K
GRX
6016
Gabelli Healthcare & Wellness Trust
GRX
$147M
$2K ﹤0.01%
225
INDL icon
6017
Direxion Daily MSCI India Bull 2X ETF
INDL
$57.1M
$2K ﹤0.01%
+50
New +$2.46K
INOD icon
6018
Innodata
INOD
$2.01B
$2K ﹤0.01%
367
-19,213
-98% -$124K
JWEL icon
6019
Jowell Global
JWEL
$7.27M
$2K ﹤0.01%
38
KORU icon
6020
Direxion Daily MSCI South Korea Bull 3X ETF
KORU
$1.59B
$2K ﹤0.01%
+472
New +$3.27K
KRRO icon
6021
Korro Bio
KRRO
$197M
$2K ﹤0.01%
26
-20,999
-100% -$1.42M
LAB icon
6022
Standard BioTools
LAB
$312M
$2K ﹤0.01%
1,311
-34,948
-96% -$86.5K
LPCN icon
6023
Lipocine
LPCN
$17M
$2K ﹤0.01%
176
OCFT
6024
DELISTED
OneConnect Financial Technology
OCFT
$2K ﹤0.01%
+109
New +$1.54K
OPK icon
6025
CALL
Opko Health
OPK
$1.04B
$2K ﹤0.01%
600

Similar funds

JP Morgan Chase's Q2 2022 Portfolio in Review

As of Q2 2022, JP Morgan Chase held 7,270 positions worth $718B, down 14% from $830B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

JP Morgan Chase's Q2 2022 filing shows 568 new, 2,561 increased, 2,729 reduced and 610 closed positions. Its largest new stake was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $4.61B.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.

  • JP Morgan Chase's largest Q2 2022 buy was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B.
  • JP Morgan Chase added most to Microsoft in Q2 2022, an estimated $2.29B increase.
  • JP Morgan Chase's biggest Q2 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $4.61B.
  • JP Morgan Chase fully exited Cerner Corp in Q2 2022, selling an estimated $608M.
  • JP Morgan Chase's ten largest holdings make up 18% of its $718B portfolio in Q2 2022.
  • JP Morgan Chase opened 568 new positions and closed 610 in Q2 2022.
  • JP Morgan Chase's portfolio value fell 14% quarter-over-quarter to $718B.

Based on JP Morgan Chase's 13F filing for Q2 2022, filed 11 Aug 2022.